Anselmo Roldan
Internal Medicine · San Diego, CANPI 1790898369
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.9% of the total across 121 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 15.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,671 and has fallen 98.6% since, to $24 in 2024.
Across 121 payments — averaging $17.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$319
- AstraZeneca$232
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$212
- Merck$169
- AbbVie$165
- Sanofi-aventis U.S. LLC$155
- plus $869 from 16 others
What the payments were for
- Speaking & faculty fees$452%
- Food & beverage$2,07798%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 15 | $319 |
| AstraZeneca | 10 | $232 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 15 | $212 |
| Merck | 10 | $169 |
| AbbVie(2 entities) | 9 | $165 |
| Sanofi-aventis U.S. LLC | 9 | $155 |
| Astellas Pharma US Inc | 8 | $148 |
| Lilly USA, LLC | 10 | $146 |
| Pfizer | 8 | $109 |
| Mannkind Corporation | 4 | $70 |
| Johnson & Johnson | 4 | $68 |
| Medtronic | 4 | $66 |
| GSK | 2 | $43 |
| Amarin Pharma, Inc. | 2 | $37 |
| Novo Nordisk | 2 | $37 |
| Teva Pharmaceuticals USA, Inc. | 2 | $29 |
| Novartis | 1 | $23 |
| Sunovion Pharmaceuticals Inc. | 2 | $22 |
| Boehringer Ingelheim | 1 | $22 |
| Roche Diagnostics Corporation | 1 | $20 |
| Neotract Inc. | 1 | $17 |
| Boston Scientific | 1 | $12 |
How this compares
$2,122 in reported general payments places this provider in the 80th percentile of 13,581 internal medicine providers in California.
Other internal medicine in San Diego
- Hatim HusainSan Diego$2M
- Steven EdelmanSan Diego$863K
- Christian RamersSan Diego$675K
- Adam ZweigSan Diego$421K
- James BreitmeyerSan Diego$227K
- Andrew ChengSouth San Francisco$55.1M
- Tung NgoNewport Beach$4.9M
- Christian EversullStanford$2.9M
- Christian SandrockSacramento$2.1M
- Teck LingPalo Alto$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.